Perfusion-CT assessment of the cerebrovascular reserve: A revisit to the acetazolamide challenges;Evaluation de la reserve cerebrovasculaire par scanner de perfusion: une revisite des tests a l'acetazolamide

Journal of Neuroradiology

Volumn 35, Issue 3, 2008, Pages 157-164

  Smith, L McG ^a   Elkins, J S ^a   Dillon, W P ^a   Schaeffer, S ^a   Wintermark, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetazolamide challenge; Carotid stenosis; Cerebrovascular reserve; Perfusion CT

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CIRCULUS ARTERIOSUS; BRAIN PERFUSION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; STENOSIS;

ACETAZOLAMIDE; ADULT; AGED; ANTICONVULSANTS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45949094700     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurad.2007.11.002     Document Type: Article

References (21)

1. Daffertshofer M., and Hennerici M. Cerebrovascular regulation and vasoneuronal coupling. J Clin Ultrasound 23 (1995) 125-138
2. Eskey C.J., and Sanelli P.C. Perfusion imaging of cerebrovascular reserve. Neuroimaging Clin N Am 15 (2005) 367-381, xi
3. Kuroda S., Shiga T., Houkin K., Ishikawa T., Katoh C., Tamaki N., et al. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease. Stroke 37 (2006) 393-398
4. Imaizumi M., Kitagawa K., Oku N., Hashikawa K., Takasawa M., Yoshikawa T., et al. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET. Ann Nucl Med 18 (2004) 369-374
5. Ogasawara K., Ogawa A., and Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 33 (2002) 1857-1862
6. Furukawa M., Kashiwagi S., Matsunaga N., Suzuki M., Kishimoto K., and Shirao S. Evaluation of cerebral perfusion parameters measured by perfusion CT in chronic cerebral ischemia: comparison with xenon CT. J Comput Assist Tomogr 26 (2002) 272-278
7. Endo H., Inoue T., Ogasawara K., Fukuda T., Kanbara Y., and Ogawa A. Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography. Stroke 37 (2006) 388-392
8. Grandin C.B., Bol A., Smith A.M., Michel C., and Cosnard G. Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatabilily and comparison with PET in humans. Neuroimage 26 (2005) 525-535
9. Ma J., Mehrkens J.H., Holtmannspoetter M., Linke R., Schmid-Elsaesser R., Steiger H.J., et al. Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT. Neuroradiology 49 (2007) 317-326
10. Zappe A.C., Reichold J., Burger C., Weber B., Buck A., Pfeuffer J., et al. Quantification of cerebral blood flow in nonhuman primates using arterial spin labeling and a two-compartment model. Magn Reson Imaging (2007)
11. Shiogai T., Koshimura M., Murata Y., Nomura H., Doi A., Makino M., et al. Acetazolamide vasoreactivity evaluated by transcranial harmonic perfusion imaging: relationship with transcranial Doppler sonography and dynamic CT. Acta Neurochir Suppl 86 (2003) 57-62
12. Shiogai T., Morisaka A., Takayasu N., Yoshikawa K., Mizuno T., Nakagawa M., et al. Quantitative evaluation of cerebrovascular reactivity in brain tissue by a refill kinetic method of transcranial ultrasonic perfusion imaging: a comparison with Doppler sonography. Acta Neurochir Suppl 95 (2005) 183-190
13. Bisdas S., Nemitz O., Berding G., Weissenborn K., Ahl B., Becker H., et al. Correlative assessment of cerebral blood flow obtained with perfusion CT and positron emission tomography in symptomatic stenotic carotid disease. Eur Radiol 16 (2006) 2220-2228
14. Chen A., Shyr M.H., Chen T.Y., Lai H.Y., Lin C.C., and Yen P.S. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. AJNR Am J Neuroradiol 27 (2006) 1876-1881
15. Eastwood J.D., Alexander M.J., Petrella J.R., and Provenzale J.M. Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. AJNR Am J Neuroradiol 23 (2002) 285-287
16. Jain R., Hoeffner E.G., Deveikis J.P., Harrigan M.R., Thompson B.G., and Mukherji S.K. Carotid perfusion CT with balloon occlusion and acetazolamide challenge test: feasibility. Radiology 231 (2004) 906-913
17. Sakamoto S., Ohba S., Shibukawa M., Kiura Y., Arita K., and Kurisu K. CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization. Acta Neurochir (Wien) 148 (2006) 77-81 discussion 81
18. Wintermark M., Chiolero R., Van Melle G., Revelly J.P., Porchet F., Regli L., et al. Cerebral vascular autoregulation assessed by perfusion-CT in severe head trauma patients. J Neuroradiol 33 1 (2006) 27-37
19. Wintermark, Maeder, Thiran, Schnyder, and Meuli. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 11 (2001) 1220-1230
20. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol 18 (1983) 94-99
21. Ladurner G., Zilkha E., Iliff D., du Boulay G.H., and Marshall J. Measurement of regional cerebral blood volume by computerized axial tomography. J Neurol Neurosurg Psychiatry 39 (1976) 152-158